Skip to content
20-F

Annual Report (Foreign)

BioLineRx Ltd. BLRX

0001178913-25-001123

← back to feed
Filed
Mar 31, 2025 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 16, 2025 2.23B sh